Companies: 10,795·Total market cap: $144.5T
Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc.

EWTXNASDAQHealthcare● Active
$35.54
$-0.06(-0.15%)
Market Cap$3.8B
P/E Ratio
52W High$40.765
52W Low$12.15
Overview

Edgewise Therapeutics, Inc. (EWTX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · EWTX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-1.66ewtx eps ttm · ewtx earnings per shareEarnings history
PE Ratio (TTM)ewtx pe ratio ttm · ewtx price to earningsPE Ratio deep dive
Revenue (TTM)0.00ewtx revenue ttm · ewtx annual revenueFull revenue history
Dividend YieldNo Dividenddoes ewtx pay dividends · ewtx dividend yieldDividend history
Shares Outstanding102.9Mewtx shares outstanding · ewtx floatShares outstanding history
Next EarningsAug 6, 2026Est.ewtx earnings date · ewtx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$0.00
202320242025
edgewise therapeutics, inc. revenue · ewtx revenue 2025
FY 2025Net Income-$167.8M▼ 25.40% YoY
202320242025
edgewise therapeutics, inc. net income · ewtx profit 2025
FY 2025EPS$-1.63▼ 12.41% YoY
202320242025
ewtx eps · edgewise therapeutics, inc. earnings per share 2025
TTM:Revenue: $0.00Net Income: -$176.0MEPS: $-1.66View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy10 analystsis ewtx a buy · ewtx analyst rating
Strong Buy
0
Buy
8
Hold
1
Sell
1
Strong Sell
0
12-Month Price Target
$25.00Low
$35.53Current
$47.57Avg Target33.87% upside
$66.00High
ewtx price target · ewtx 12 month forecast

Total: 10 · Buy rate: 80.0%

The EWTX analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $47.57, representing +33.87% upside from the current price of $35.53.

Stock Performance

Full History
1D+0.15%
1W-6.28%
1M+0.92%
3M+28.12%
YTD+43.61%
1Y+133.57%
5Y+33.10%

About Edgewise Therapeutics, Inc.

CEOKevin Koch
IPO DateMar 26, 2021
Employees117
CountryUS

Edgewise Therapeutics, Inc. a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered smal…

what is edgewise therapeutics, inc. · ewtx stock overview · edgewise therapeutics, inc. company profile · who is edgewise therapeutics, inc. ceo · ewtx NASDAQ · edgewise therapeutics, inc. headquarters · edgewise therapeutics, inc. business segments

About Stock Overview & Key Data

Edgewise Therapeutics, Inc. (EWTX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Mar 26, 2021. As of the latest trading session, EWTX stock price is $35.53, with a market capitalization of $3.8B. The stock has returned +133.57% over the past 12 months and +43.61% year-to-date.

According to 10 Wall Street analysts, the consensus rating for Edgewise Therapeutics, Inc. stock is Buy, with an average 12-month price target of $47.57. In fiscal year 2025, Edgewise Therapeutics, Inc. reported revenue of — and net income of -$167.8M. For detailed data — including Edgewise Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Edgewise Therapeutics, Inc. (EWTX) stock price is $35.53. The stock is traded on NASDAQ under the ticker symbol EWTX. The 52-week range is $12.15 – $40.77.

EWTX stock priceEWTX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice